Oncologic Imaging by Shim, John J. & Chen, Andrew
University of Massachusetts Medical School 
eScholarship@UMMS 
Cancer Concepts: A Guidebook for the Non-
Oncologist Radiation Oncology 
2016-02-17 
Oncologic Imaging 
John J. Shim 
David Geffen School of Medicine at UCLA 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/cancer_concepts 
 Part of the Neoplasms Commons, Oncology Commons, and the Radiology Commons 
Repository Citation 
Shim JJ, Chen A. (2016). Oncologic Imaging. Cancer Concepts: A Guidebook for the Non-Oncologist. 
https://doi.org/10.7191/cancer_concepts.1017. Retrieved from https://escholarship.umassmed.edu/
cancer_concepts/20 
Creative Commons License 
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Cancer Concepts: A 
Guidebook for the Non-Oncologist by an authorized administrator of eScholarship@UMMS. For more information, 
please contact Lisa.Palmer@umassmed.edu. 
Oncologic Imaging 
 
 
Cancer Concepts: A Guidebook for the Non-Oncologist   (17 February 2016) 
1 
John J. Shim, MD 
Andrew Chen, MD 
 
 
  
 
 
 
 
Summary and Key Points 
1. Radiology is important in the detection, diagnosis and staging of 
cancer. Diagnostic imaging is integral to guide treatment planning, 
assess for residual disease and response to the treatment, and 
monitor recurrence and progression of most malignancies. 
2. Commonly used modalities for oncologic imaging include Computed 
Tomography, Magnetic Resonance Imaging, Positron Emission 
Tomography/Computed Tomography, mammography, and 
ultrasound. 
Introduction 
Imaging is an integral part of the multidisciplinary management of 
cancer.1 Radiographic techniques are indispensable for proper staging of 
cancers and evaluation of the response of tumors to treatment. A wide 
variety of imaging modalities is available to clinicians. This chapter will 
introduce the role of radiology in the diagnosis and treatment of cancer. 
Radiology in Staging 
Staging of cancer is a way to describe the extent of spread of a tumor 
throughout the body. Each malignancy has a unique staging system; 
however the TNM classification is the most widely used staging system. 
Radiology is integral to staging the various malignancies using 
noninvasive techniques. Tumor (T) size, location, and regional 
involvement can be assessed radiographically. Nodal (N) and metastatic 
(M) disease may also be staged. 
Radiologic staging becomes especially important to guide treatment 
planning. As an example, cervical cancer staging by ultrasound or MRI 
can determine whether a patient’s tumor is operable. MRI, in particular, 
demonstrates exquisite soft tissue detail (Figures 1a- c). For example, 
when parametrial invasion from a cervical cancer is identified, patients 
are classified as Stage IIB for which radiation and chemotherapy are the 
treatment of choice over primary resection. 
 
Figure 1a. Sagittal contrast MRI. University of Massachusetts Medical School, 
Department of Radiology. 
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Figure 1b. Axial contrast MRI. Stage IVa with bladder involvement resulting in 
hydroureter (not shown). University of Massachusetts Medical School, 
Department of Radiology. 
 
Figure 1c. Pelvic ultrasound. University of Massachusetts Medical School, 
Department of Radiology. 
Functional imaging with PET/CT, and dynamic contrast enhanced 
CT/MRI are being used to assess tumor response to therapy. The 
Response Evaluation Criteria In Solid Tumor (RECIST) provides 
guidelines for the categorization of treatment responses into four 
groups:2 
Treatment 
Response 
Definition 
Complete 
Response (CR) 
Disappearance of all target lesions. Any pathological 
lymph nodes (whether target or non-target) must have 
reduction in short axis to <10 mm. 
Partial 
Response (PR) 
≥ 30% decrease in the sum of the longest diameter 
(SLD) of target lesions  
Stable Disease 
(SD) 
Persistence of non-target lesion(s) and/or 
maintenance of tumor marker level above the normal 
limits 
Progression of 
Disease (PD) 
> 20% increase in the SLD (min 5mm increase) OR 
the appearance of one or more new lesions and/or 
unequivocal progression of existing non-target 
lesions. 
Tumor assessment early in the course of treatment can be very helpful. If 
tumor growth (progression) is seen despite treatment, then it will be 
necessary to discontinue potentially toxic therapies that are not working 
and/or to switch to therapies that may be more effective. 
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Modalities 
X-ray/ Fluoroscopy/ Mammography 
X-ray 
Plain film radiography (X-ray) (Figures 2a-d) is rarely used in cancer 
imaging. Plain X-rays offer the benefit of an inexpensive, low radiation 
modality and may be used for: 
- bone tumor characterization 
- screening for tumor3 
- interval surveillance of tumor 
 
Figures 2a-b. Left upper lobe (LUL) mass. Figure 2a: AP x-ray. Figure 2b: Left 
lateral x-ray. University of Massachusetts Medical School, Department of 
Radiology. 
 
 
 
 
 
Figure 2c. AP x-ray demonstrating leiomyosarcoma metastasis to lung. 
University of Massachusetts Medical School, Department of Radiology. 
 
Figure 2d. Well-defined lytic lesion in 2nd proximal phalanx consistent with 
benign enchondroma. University of Massachusetts Medical School, Department 
of Radiology. 
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Fluoroscopy 
Fluoroscopy incorporates rapid or continuous imaging with an x-ray 
beam to dynamically image patients. These studies include the 
esophagram, upper GI series, and barium enema. Fluoroscopy is rarely 
used as the primary method of diagnosis due to more advanced imaging 
modalities. However, it still maintains value in assessing physiologic 
function over a period of time, such as the severity of stenosis from a 
mass at the gastroesophageal junction (Figures 3-4). 
  
Figure 3. Esophogram with malignant mass effect extending up from GE 
junction. University of Massachusetts Medical School, Department of Radiology. 
 
Figure 4. Screen capture of a fluoroscopic examination demonstrating a mass 
lesion causing narrowing of ileocecal valve. Diagnosis: carcinoid. University of 
Massachusetts Medical School, Department of Radiology. 
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Mammography 
Mammography is an essential modality for the screening and 
management of breast cancer.4 With relative low radiation exposure, 
high resolution images of the breast parenchyma can be studied for soft 
tissue masses or microcalcifications which can be associated with ductal 
carcinoma (Figures 5a-b). MRI is a very useful adjunct to mammography 
in diagnostically challenging cases such as in patients with dense 
glandular tissues or from scar tissue due to prior surgery. 
 
Figures 5a-b. Left breast mass with spiculated margins. University of 
Massachusetts Medical School, Department of Radiology. 
Ultrasound 
In ultrasonography, a small transducer with a piezoelectric ceramic 
element rapidly vibrates up to 20 million times per second creating 
sounds waves that pass through the body. The sound waves are 
reflected back to the transducer dependent on the acoustic 
characteristics of the tissue; these reflections are used to create the 
sonogram. Although comprehensive staging cannot be performed with 
ultrasound alone, ultrasound has high spatial resolution for superficial 
structures. It lacks ionizing radiation and allows for continuous imaging 
that makes it the modality of choice for image guided biopsies. 
Ultrasound works best for structures located next to the probe. Such 
areas include superficial structures such as the thyroid gland, breasts, 
liver, and kidneys. Transvaginal ultrasound is routinely used for detailed 
assessment of the female pelvic structures. Additionally, small 
transducers have been fitted onto endoscopes for detailed imaging of 
esophageal, pancreatic, and colorectal malignancies. Doppler ultrasound 
also allows the radiologist to obtain blood flow characteristics of an organ 
or tumor. 
 
Figure 6. US of the right breast with a 5 cm mass. University of Massachusetts 
Medical School, Department of Radiology. 
Computerized Tomography (CT) 
In the late 1970’s, CT scanning was developed using a rotating x-ray 
source and detector, allowing for the creation of cross-sectional imaging. 
Intravascular and oral contrast may be used with CT to provide better 
definition of vascular structures, organs, and the digestive tract. 
Advances in technology, sub-millimeter pictures, and rapid acquisition 
techniques have enabled us to create high resolution images, reformat 
the images in different cross-sectional planes, create 3D images (Figure 
7a-b), and develop new techniques such as Virtual Colonoscopy. 
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Figure 7a. CT study timed at the arterial phase of the contrast bolus (CT 
angiography) demonstrates a ruptured abdominal aortic aneurysm (AAA). Static 
sagittal reformatted contrast enhanced CT. University of Massachusetts Medical 
School, Department of Radiology. 
 
Figure 7b (movie). CT angiography of a ruptured AAA. 3D MIP (maximum 
intensity projection) images demonstrating only selected structures. University of 
Massachusetts Medical School, Department of Radiology. 
Interpreting the images generated from a CT scanner requires a basic 
understanding of the physics involved. CT acquires images by passing x-
rays circumferentially through the body. Attenuation of the x-rays as they 
pass through varying densities is recorded. This information is converted 
by the scanner into Hounsfield units (HU) which is a standardized 
method for measuring linear attenuation. At standard pressure and 
temperature, the density of distilled water is defined as zero HU, while 
the density of air is defined as -1000 HU. These standards were chosen 
as they are universally available references.5 
By convention, the less dense objects are displayed as black and higher 
density such as bone and intravascular contrast are displayed as white 
(Figure 8). 
 
Figure 8. Structures from the least dense (black) to the most dense (white): 
Air < Fat < Muscle < Contrast (heart and vessels) < Bone 
Right Atrium (RA), Left Atrium (LA) Right Ventricle (RV) 
University of Massachusetts Medical School, Department of Radiology. 
One practical application in CT evaluation of tumors is in the diagnosis of 
a lipoma, where the density of the tumor is purely fat. Another example is 
with the evaluation of adrenal tumors where an average density of less 
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than 10 HU indicates a predominately fatty composition, diagnostic of a 
benign adrenal adenoma. 
The drawback to CT imaging is the use of x-ray (ionizing) radiation in 
much higher doses (150 - 1,100 times) than seen with plain radiographs. 
Recent technical innovations have lowered the radiation dose from CT 
imaging; however, the ordering physicians must be aware of the small, 
but real, risk for medically induced cancers. The decision for the use of 
CT needs to weigh the risks versus benefits as well as the cumulative 
effect from multiple CTs over a lifetime. 
Magnetic Resonance Imaging (MRI) 
MRI provides superb contrast resolution (tissue differentiation) at the 
cost of lower spatial resolution (image clarity) compared with CT. 
Patients are placed within a large magnetic field created either by a 
permanent magnetic or liquid nitrogen cooled superconductor. 
Radiofrequency pulses generate signal based on the different tissue 
characteristics, which is then interpreted into images by the scanner. 
Images can be provided from various angles and constructed into a three 
dimensional image. Imaging of the brain/spine, liver, and pelvis heavily 
rely on MR imaging for the increased sensitivity and specificity compared 
with CT (Figures 9a-b). Advances with functional MRI and MR 
Spectroscopy are continually being explored with clinical and research 
applications (Figures 10a-b). 
 
Figures 9a-b. Figure 9a: CT of the lumbar spine show a lytic tumor eroding 
through the posterior vertebral body of the L3 vertebrae. Figure 9b: MR of the 
lumbar spine allows much better assessment of the soft tissues. In this case, the 
posterior extent of this tumor invades the spinal canal and compresses the 
adjacent nerve roots. University of Massachusetts Medical School, Department 
of Radiology. 
 
Figures 10a-b. Figure 10a: MRI of the brain demonstrates a new lesion in the 
inferior right frontal lobe in a patient with a history of brain tumor resection. This 
may represent residual tumor or post-surgical/radiation change. Figure 10b: The 
addition of MR Spectroscopy shows abnormally reduced creatine and N-
acetylaspartate indicating that this lesion represents progression of tumor. 
University of Massachusetts Medical School, Department of Radiology. 
Contraindications to MRI are related to the strong magnetic field (10,000 
to 300,000 times the field strength on the Earth's surface). This excludes 
patients with ferromagnetic material implanted in the body (pacemaker, 
certain aneurysm clips, deep nerve stimulators, endoscopy capsules, 
Swan-Ganz catheters, etc). Even certain tattoo inks contain elements of 
iron that have been reported to be a cause of thermal injury from 
electromagnetic induction. A comprehensive list of these items is found 
at http://www.mrisafety.com. 
Contrast agents 
Contrast agents increase the sensitivity of conventional imaging by 
improving visibility of internal body structures. These agents distribute 
proportional to blood flow allowing better visualization of hypervascular 
lesions. Radiocontrast for X-ray based imaging, MRI contrast and 
microbubbles (ultrasound) are used in order to enhance their respective 
imaging modalities. 
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Radiocontrast agents are used in X-ray based imaging such as CT, 
fluoroscopy, and radiography. These agents take advantage of a 
difference in density between the contrast agent and adjacent structures. 
Iodine and barium agents are commonly used agents. Modern 
intravenous contrast agents are based around iodine. Iodine may be 
administered as an ionic compound or non-ionic (organic) compound. 
The ionic form was initially developed and widely used, but fell out of 
favor due to potential complications such as renal failure. The organic 
form which covalently binds iodine has fewer complications and is now 
the primary contrast enhancing agent for CT. In addition to evaluation of 
the soft tissues for tumor, infection, and inflammation, iodine is used in 
angiography (arterial investigation), venography (venous investigation), 
voiding cystourethrography (VCUG), hysterosalpingogram (HSG), 
intravenous urography (IVU), and myelography. 
Contrast-induced nephropathy (CIN) is a major side effect of iodinated 
intravascular contrast. This is defined as renal injury as a consequence 
of radiocontrast resulting in either a greater than 25% increase of serum 
creatinine or an absolute increase in serum creatinine of 0.5 mg/dL. 
These agents should be avoided in patients with poor renal function. 
Barium is mainly used in the imaging of the digestive system. Barium is 
administered as barium sulfate, a water-insoluble compound. Typical 
studies that utilize barium include, barium swallow (oro-esophageal 
investigation), barium upper GI (stomach investigation), barium upper GI 
and follow through (stomach and small bowel investigation), barium 
enema (large bowel investigation). 
MRI contrast agents improve visibility of internal structures in magnetic 
resonance imaging. Most commonly used agents are gadolinium-based. 
The primary mechanism through which MRI functions is in the evaluation 
of the spin of protons- the most predominate form in the body– the water 
molecule. Molecular rotational oscillations of the water molecule behave 
differently in different tissues, which are used to generate MR images. 
Gadolinium based agents alter the spin of adjacent protons resulting in 
enhancement. Effectively, more gadolinium within a tissue equates to 
more enhancement. Like CT contrast, higher concentrations of MR 
contrast are seen in pathology that has greater vascularity and 
permeability such as tumors, infection, and inflammation. This is 
particularly effective in evaluation of brain tumors where disruption of the 
blood-brain barrier allows enhancement of these lesions where the intact 
blood-brain barrier prevents passage of the gadolinium chelate. 
Gadolinium contrast agents have not proven safer than radiocontrast 
agents. The free solubilized gadolinium ion is toxic and its deposition in 
tissues is thought to be the primary cause of nephrogenic fibrosing 
dermopathy, also known as nephrogenic systemic fibrosis (NSF). This 
systemic disease most closely resembles scleromyxedema. Patients with 
poor renal function are at more risk for NSF. Dialysis has not been 
proven effective in the removal of free gadolinium ions and gadolinium 
based contrast should be avoided in patients on dialysis. Gadolinium is 
administered as a chelated compound. The stronger the chelating agent 
bond, less likely to have free ions, hence less risk for NSF. In addition, 
different characteristics of the chelating agent have been shown to alter 
the pharmacokinetics. Such novel research in altering the 
pharmacokinetics has proven effective in differentiating benign versus 
malignant liver lesions. 
Perfusion imaging is also a novel technique to help differentiate tumor 
from radiation-induced changes, as both may enhance. 
Neoangiogenesis seen with tumor growth results in an abnormal 
increase in vascular flow and permeability. This alteration in vascularity 
can be detected by perfusion imaging either by contrast enhanced CT or 
MRI, thus differentiating tumor from radiation necrosis. This has been 
shown to be particularly helpful in the management of brain tumors 
where radiation is often used to treat tumors. 
Radiologic contrast media are considered among the most heavily 
studied medications when it comes to allergic reactions. While rare, 
anaphylactoid reactions can occur and are potentially life threatening. 
Pretreatment with corticosteroids has been shown to decrease the 
incidence of adverse events. 
Microbubble contrast agents may be used in ultrasound. These bubbles 
are composed of agitated saline solution ranging in size, typically 
between 1-4 micrometers. It is not currently used in oncologic imaging, 
but has been shown to be helpful in echocardiograms for the detection of 
cardiac shunts. 
Nuclear Medicine 
The division of nuclear medicine uses physiologic/functional imaging to 
provide valuable information that may not be obtained through the 
anatomic imaging discussed above. The basis of nuclear medicine is to 
inject radioactive isotopes bound to specific radiopharmaceuticals, and 
image the resultant radioactive decay based on physiologic localization. 
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Unlike CT, ultrasound, or MRI, the multitude of radiopharmaceuticals 
involved in each exam create a unique image and address very specific 
issues in diagnosis and treatment. Examples of nuclear medicine studies 
used in oncologic imaging include bone scans (Technetium 99m-MDP) 
(Figure 11), neuroendocrine tumor imaging (Indium-111 pentotreotide, 
Iodine-123 metaiodobenzylguanidine), and CD20 antibody imaging 
(Indium-111 Zevalin). Lymphoscintigraphy (Technetium 99m– sulfur 
colloid) is another commonly ordered study to aid in sentinel lymph node 
biopsy. New molecular markers are being studied for future clinical use, 
and show considerable promise in the field of oncologic imaging. 
Additional information about the mechanism of uptake and uses for these 
scans can be found at AuntMinnie.com. 
 
Figure 11. Bone scan demonstrating superscan with prostate metastases.  
University of Massachusetts Medical School, Department of Radiology. 
Positron Emission Tomography (PET) 
Positron emission tomography is a functional imaging technique that 
detects gamma rays emitted by the annihilation reaction of a positron-
emitting radionuclide (tracer). The most common and widely used PET 
agent is fluoro-18-deoxyglucose (FDG). This glucose analog can be 
administered intravenously and has an identical physiologic distribution 
as its parent molecule. 
FDG accumulation occurs in normal glucose-avid organs like the brain, 
salivary glands, liver, and bowel. A large percentage of malignancies are 
hypermetabolic with increased tracer uptake. This is helpful for 
diagnosis, staging, and monitoring for disease recurrence (Figures 12 & 
13). Examples include non-small cell lung cancer, breast cancer, 
colorectal cancer, pelvic malignancies, lymphoma, sarcomas, and 
head/neck cancer. Many ongoing clinical trials are evaluating whether 
FDG can also be used to predict treatment response and help refine 
therapy planning. 
 
 
 
Figure 12a (movie). Normal FDG PET rotating MIP. Physiologic bowel uptake. 
University of Massachusetts Medical School, Department of Radiology. 
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Figure 12b. PET scan of diffuse breast cancer metastases. University of 
Massachusetts Medical School, Department of Radiology. 
 
Figure 13a, b, c. Normal patient. PET and CT are commonly acquired together. 
Figure 13a. PET allows evaluation of metabolic activity, but tends to have poor 
resolution. Figure 13b. CT has high spatial resolution. Figure 13c. Merging PET 
and CT allows for more accurate evaluation of the anatomical structures and 
their metabolic activity. University of Massachusetts Medical School, Department 
of Radiology. 
 
 
 
 
 
 
Figure 14a, b, c. Melanoma metastasis. Figure 14a. Abnormal increase in 
metabolic activity is seen in the posterior right upper neck. Figure 14b. Detection 
of subtle metastasis can be challenging by CT. Figure 14c. Fusion of PET and 
CT images better identifies the anatomic structures around this metastasis. 
University of Massachusetts Medical School, Department of Radiology. 
As with other nuclear medicine agents, patient preparation can be an 
important part of getting accurate results. Recent glucose ingestion will 
act as a competitive inhibitor, decreasing the sensitivity for malignant 
disease. Insulin (endogenous or exogenous) can alter glucose dynamics 
and also decrease sensitivity for oncologic imaging. Because the 
biodistribution of the FDG molecule is dependent on where glucose is 
being metabolized, exercise prior to the study will drive uptake into the 
skeletal muscles and again decrease sensitivity. Guidelines for proper 
patient preparation can be found at the National Cancer Institute FDG 
PET Guidelines. 
Conclusion 
Oncologic imaging is a continually evolving field with clinical applications 
that directly and indirectly impact the patient’s outcome. Each modality 
has advantages and disadvantages depending on the question being 
answered and sometimes the evaluation may require more than one 
imaging modality. Radiology consultation may be helpful to determine 
the most appropriate imaging study. Every physician is expected to be 
able to, at the least, review the images ordered and compare his 
impression with the official diagnostic radiologist interpretation. 
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Thought Questions 
1. A 68 year old man with a T1, N0 (Stage I) squamous cell carcinoma 
of the lung undergoes a left upper lobectomy. Four months later, a 
chest CT shows no evidence of tumor. He continues with regular 
check-ups consisting of physical exams and periodic chest CTs. 18 
months after his surgery another chest CT shows an enlarged right 
mediastinal lymph node. Biopsy of the node shows squamous cell 
cancer. The patient and his family wonder why the abnormality was 
not seen previously. They wonder why his physicians did not have 
him get regular MRIs or PET scans. How could you answer them? 
Your answer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expert Answer 
2. A 22 year old woman was successfully treated for Hodgkin Disease 
three years ago. Her physician still wants to her to have CT scans 
periodically, but she is concerned about exposure to x-rays. What 
can you tell her about the differences in radiation exposure from 
chest x-rays, chest CTs, chest MRI, breast ultrasound, and PET 
scan? 
Your answer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expert Answer 
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3. A 52 year old woman has a routine screening mammogram that 
detects a mass in her right breast. An ultrasound is obtained that 
shows a mass that is consistent with a fibroadenoma. An MRI of the 
breast shows a mass that enhances with gadolinium. At this point the 
patient is thoroughly confused about why she had all these different 
imaging studies. What can you tell her about how these modes of 
imaging provide different information about a breast mass? 
Your answer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expert Answer 
 
 
 
 
 
 
 
 
 
 
Glossary 
CT angiography- Computerized tomography (CT) angiography or map of 
the blood vessels performed with computerized tomography 
Endogenous- Substrate of process that occurs within the body 
Exogenous- Substrate of process that occurs outside the body and can 
be administered to the patient 
Functional imaging- Images based on physiologic distribution rather than 
anatomic or structural characteristics 
Hounsfield units (HU)- A linear scale based for radiodensity with water 
defined as 0 HU 
Microbubbles- Ultrasound contrast agent constructed of 1-4 µm bubbles 
of gas surrounded by a thin shell 
Nephrogenic systemic fibrosis- Rare condition causing fibrosis of the 
skin, joints and internal organs associated with Gadolinium contrast in 
patients with renal failure 
Nephropathy- Damage to the kidney 
Noninvasive radiology techniques- Procedures that do not penetrate into 
the body. Almost all diagnostic imaging falls into this category 
Piezoelectric- Process that converts electrical input into mechanical 
output (vibration) and vice versa 
Staging- Procedure to determine where and how much cancer is in a 
patient 
Treatment response- Effects of usually noninvasive therapies on disease 
burden 
Virtual Colonoscopy- CT procedure using air distension to evaluate the 
colon similar to what would be seen during a colonoscopy 
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